Literature DB >> 19882263

Single-nucleotide polymorphism (SNP) analysis to associate cancer risk.

Julie Earl1, William Greenhalf.   

Abstract

Identification of hereditary factors that predispose to cancer allows targeted cancer screening and better quantification of environmental risk factors. The ability to identify which single nucleotide polymorphisms (SNPs) are associated with cancer or segregate with disease in families allows high-risk loci to be identified. In this chapter, two platforms for analysing SNPs are discussed, the Affymetrix and Illumina systems. Application of both platforms requires the same principles of good laboratory practice but there are important differences in materials and methods, which will be discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19882263     DOI: 10.1007/978-1-59745-545-9_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine.

Authors:  Kunie Sakurai; Andreas Kurtz; Glyn Stacey; Michael Sheldon; Wataru Fujibuchi
Journal:  Stem Cells Transl Med       Date:  2016-07-12       Impact factor: 6.940

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.